University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
Follow
Contributor content
Presentation
Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality - insights from the german ablation registry
